Vasilii P. Akimov
Research Subjects
Vasilii P. Akimov has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Nune V. Matinyan
N.N. Blokhin National Medical Research Centre of Oncology, Ministry of Health of Russia; N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia
5 shared publications - Anastasia A. Tsintsadze
Blokhin National Medical Research Center of Oncology
2 shared publications - Dmitry A. Kuznetsov
Blokhin National Medical Research Center of Oncology
2 shared publications - E. A. Kovaleva
Blokhin National Medical Research Center of Oncology, Moscow, Russia
2 shared publications - Ekaterina A. Kovaleva
N.N. Blokhin National Medical Research Centre of Oncology, Ministry of Health of Russia
2 shared publications - Ekaterina I. Belousova
N.N. Blokhin National Medical Research Centre of Oncology, Ministry of Health of Russia
2 shared publications
Latest Publications
- 24 June 2026
- Published by FSBEI HE I.P. Pavlov SPbSMU MOH Russia in Messenger of ANESTHESIOLOGY AND RESUSCITATION
- Vol. 23 (3)
The use of intraoperative ECMO support in pediatric oncosurgery: a clinical observation
Introduction . Spontaneous pneumothorax as the onset of metastatic osteosarcoma in children is extremely rare. In the present case, massive involvement of the peripheral lung segments in a patient with osteosarcoma of the right tibia led to the development of bilateral spontaneous pneumothorax. Effective polychemotherapy resulted in a significant reduction in the number of metastases; however, the extensive adhesions that formed against the background of metastatic regression, combined with the multiple pleural drainages performed at the onset of the disease, created obstacles to further surgical treatment. The objective was to demonstrate the successful use of intraoperative veno-venous extracorporeal membrane oxygenation (VV-ECMO) to prevent critical respiratory complications and ensure the safety of anesthetic management. Materials and methods . We present the clinical case of a 15-year-old patient with osteosarcoma of the right tibia (stage T2N1M1). Due to the development of bilateral pneumothorax and the formation of massive adhesions in the pleural cavities, which prevented full lung expansion, bilateral thoracic surgery (adhesiolysis) was performed under intraoperative VV-ECMO. Results . The use of VV-ECMO allowed for the safe performance of complete adhesiolysis, the re-expansion of both lungs, and the creation of conditions for subsequent radical treatment. The duration of ECMO support was 31 hours. Six weeks later, the patient successfully underwent right knee arthroplasty. The patient resumed his chemotherapy regimen. Conclusion . This clinical case demonstrates that VV-ECMO can be effectively used not only as a method of emergency respiratory support but also as a routine tool for ensuring surgical safety in patients with severe respiratory limitations. The use of ECMO made it possible to overcome the limitations associated with the inability to safely ventilate the lungs, ensuring that adhesiolysis could be performed, followed by a transition to the radical phase of treatment six weeks later.
- 24 June 2026
- Published by FSBEI HE I.P. Pavlov SPbSMU MOH Russia in Messenger of ANESTHESIOLOGY AND RESUSCITATION
- Vol. 23 (3)
The use of intraoperative ECMO support in pediatric oncosurgery: a clinical observation
Introduction . Spontaneous pneumothorax as the onset of metastatic osteosarcoma in children is extremely rare. In the present case, massive involvement of the peripheral lung segments in a patient with osteosarcoma of the right tibia led to the development of bilateral spontaneous pneumothorax. Effective polychemotherapy resulted in a significant reduction in the number of metastases; however, the extensive adhesions that formed against the background of metastatic regression, combined with the multiple pleural drainages performed at the onset of the disease, created obstacles to further surgical treatment. The objective was to demonstrate the successful use of intraoperative veno-venous extracorporeal membrane oxygenation (VV-ECMO) to prevent critical respiratory complications and ensure the safety of anesthetic management. Materials and methods . We present the clinical case of a 15-year-old patient with osteosarcoma of the right tibia (stage T2N1M1). Due to the development of bilateral pneumothorax and the formation of massive adhesions in the pleural cavities, which prevented full lung expansion, bilateral thoracic surgery (adhesiolysis) was performed under intraoperative VV-ECMO. Results . The use of VV-ECMO allowed for the safe performance of complete adhesiolysis, the re-expansion of both lungs, and the creation of conditions for subsequent radical treatment. The duration of ECMO support was 31 hours. Six weeks later, the patient successfully underwent right knee arthroplasty. The patient resumed his chemotherapy regimen. Conclusion . This clinical case demonstrates that VV-ECMO can be effectively used not only as a method of emergency respiratory support but also as a routine tool for ensuring surgical safety in patients with severe respiratory limitations. The use of ECMO made it possible to overcome the limitations associated with the inability to safely ventilate the lungs, ensuring that adhesiolysis could be performed, followed by a transition to the radical phase of treatment six weeks later.
- Open Access
- 31 January 2023
- Published by Practical Medicine Publishing House in Annals of Critical Care
- No. 1,p. 115-122
Current trends in the diagnosis and treatment of acute tumor lysis syndrome in children: a review
INTRODUCTION: Acute tumor lysis syndrome (ATLS) complicates the treatment of highly aggressive leukemia, lymphomas in children and is accompanied by a fatal outcome in 21.4 % of patients. The basis of ATLS is the decay of tumor cells, in which the volume of decay products exceeds the excretory capabilities of the kidneys. The ATLS risk group includes patients with acute lymphoblastic leukemia accompanied by hyperleukocytosis (above 100×109/L) and non-Hodgkin's lymphomas with a large tumor mass (III–IV stages of the disease). To date, the volume of thematic publications in the aggregator of the PubMed medical database is not so large: over the past 10 years, there have been 12 articles, which makes the task of systematizing previously accumulated and recently received information even more relevant for the practitioner. OBJECTIVE: Generalization of the modern scientific base for the diagnosis and treatment of ATLS in children. MATERIALS AND METHODS: To highlight the modern scientific base concerning the diagnosis and treatment of ATLS in children with oncohematological diseases, a search was conducted in PubMed, Research Gate, Web of Science Core Collection and Google Scholar systems for the period from 2000 to August 2022. RESULTS: In total, 94 articles were found, including 1 systematic review with meta-analysis and 16 review articles that meet the requirements. CONCLUSIONS: Conservative ATLS prophylaxis is effective in 93.4–93.6 % of patients. However, in 8.8–21.4 % of patients, ATLS acquires a rapid character, accompanied by the lack of the ability to conservatively correct the indicators of potassium, phosphorus, uric acid. Additional study of the pathogenetic mechanisms of the complication, identification of key targets of drug therapy and a multidisciplinary approach in the treatment of an extremely prognostically unfavorable group of oncohematological patients with advanced stages of the tumor process are possible components of further improving the effectiveness of ATLS therapy. АКТУАЛЬНОСТЬ: Синдром острого лизиса опухоли (СОЛО) осложняет лечение высокоагрессивных лейкозов, лимфом у детей и сопровождается летальным исходом у 21,4 % больных. В основе СОЛО лежит распад опухолевых клеток, при котором объем продуктов распада превышает экскреторные возможности почек. В группу риска СОЛО входят пациенты с острым лимфобластным лейкозом, сопровождающимся гиперлейкоцитозом (выше 100×109/л) и неходжкинскими лимфомами с большой опухолевой массой (III–IV стадии заболевания). К настоящему времени объем тематических публикаций в агрегаторе медицинской базы данных PubMed не столь велик: за последние 10 лет насчитывает 12 статей, что делает задачу систематизации ранее накопленной и полученной в последнее время информации для практикующего врача еще более актуальной. ЦЕЛЬ ИССЛЕДОВАНИЯ: Обобщение современной научной базы по диагностике и лечению СОЛО у детей. МАТЕРИАЛЫ И МЕТОДЫ: Для освещения современной научной базы, касающейся диагностики и лечения СОЛО у детей с онкогематологическими заболеваниями, был проведен поиск в системах PubMed, ResearchGate, Web of Science Core Collection и Google Scholar за период с 2000 г. по август 2022 г. РЕЗУЛЬТАТЫ: В целом было обнаружено 94 статьи, из них 1 систематический обзор с метаанализом и 16 обзорных статей, соответствующих предъявляемым требованиям. ВЫВОДЫ: Консервативная профилактика СОЛО (инфузионная терапия, применение аллопуринола и расбуриказы, начало противоопухолевого лечения с циторедуктивной префазы) оказывается эффективной у 93,4–93,6 % больных. Однако, по некоторым данным, у 8,8–21,4 % пациентов СОЛО приобретает стремительный характер, сопровождаясь отсутствием возможности консервативно корригировать показатели калия, фосфора, мочевой кислоты. Дополнительное изучение патогенетических механизмов осложнения, определение ключевых мишеней лекарственной терапии и мультидисциплинарный подход в лечении крайне прогностически неблагоприятной группы онкогематологических больных с распространенными стадиями опухолевого процесса — возможные составляющие дальнейшего повышения эффективности терапии СОЛО.
- 31 January 2023
- Published by Practical Medicine Publishing House in Annals of Critical Care
- No. 1,p. 115-122
Open AccessCurrent trends in the diagnosis and treatment of acute tumor lysis syndrome in children: a review
INTRODUCTION: Acute tumor lysis syndrome (ATLS) complicates the treatment of highly aggressive leukemia, lymphomas in children and is accompanied by a fatal outcome in 21.4 % of patients. The basis of ATLS is the decay of tumor cells, in which the volume of decay products exceeds the excretory capabilities of the kidneys. The ATLS risk group includes patients with acute lymphoblastic leukemia accompanied by hyperleukocytosis (above 100×109/L) and non-Hodgkin's lymphomas with a large tumor mass (III–IV stages of the disease). To date, the volume of thematic publications in the aggregator of the PubMed medical database is not so large: over the past 10 years, there have been 12 articles, which makes the task of systematizing previously accumulated and recently received information even more relevant for the practitioner. OBJECTIVE: Generalization of the modern scientific base for the diagnosis and treatment of ATLS in children. MATERIALS AND METHODS: To highlight the modern scientific base concerning the diagnosis and treatment of ATLS in children with oncohematological diseases, a search was conducted in PubMed, Research Gate, Web of Science Core Collection and Google Scholar systems for the period from 2000 to August 2022. RESULTS: In total, 94 articles were found, including 1 systematic review with meta-analysis and 16 review articles that meet the requirements. CONCLUSIONS: Conservative ATLS prophylaxis is effective in 93.4–93.6 % of patients. However, in 8.8–21.4 % of patients, ATLS acquires a rapid character, accompanied by the lack of the ability to conservatively correct the indicators of potassium, phosphorus, uric acid. Additional study of the pathogenetic mechanisms of the complication, identification of key targets of drug therapy and a multidisciplinary approach in the treatment of an extremely prognostically unfavorable group of oncohematological patients with advanced stages of the tumor process are possible components of further improving the effectiveness of ATLS therapy. АКТУАЛЬНОСТЬ: Синдром острого лизиса опухоли (СОЛО) осложняет лечение высокоагрессивных лейкозов, лимфом у детей и сопровождается летальным исходом у 21,4 % больных. В основе СОЛО лежит распад опухолевых клеток, при котором объем продуктов распада превышает экскреторные возможности почек. В группу риска СОЛО входят пациенты с острым лимфобластным лейкозом, сопровождающимся гиперлейкоцитозом (выше 100×109/л) и неходжкинскими лимфомами с большой опухолевой массой (III–IV стадии заболевания). К настоящему времени объем тематических публикаций в агрегаторе медицинской базы данных PubMed не столь велик: за последние 10 лет насчитывает 12 статей, что делает задачу систематизации ранее накопленной и полученной в последнее время информации для практикующего врача еще более актуальной. ЦЕЛЬ ИССЛЕДОВАНИЯ: Обобщение современной научной базы по диагностике и лечению СОЛО у детей. МАТЕРИАЛЫ И МЕТОДЫ: Для освещения современной научной базы, касающейся диагностики и лечения СОЛО у детей с онкогематологическими заболеваниями, был проведен поиск в системах PubMed, ResearchGate, Web of Science Core Collection и Google Scholar за период с 2000 г. по август 2022 г. РЕЗУЛЬТАТЫ: В целом было обнаружено 94 статьи, из них 1 систематический обзор с метаанализом и 16 обзорных статей, соответствующих предъявляемым требованиям. ВЫВОДЫ: Консервативная профилактика СОЛО (инфузионная терапия, применение аллопуринола и расбуриказы, начало противоопухолевого лечения с циторедуктивной префазы) оказывается эффективной у 93,4–93,6 % больных. Однако, по некоторым данным, у 8,8–21,4 % пациентов СОЛО приобретает стремительный характер, сопровождаясь отсутствием возможности консервативно корригировать показатели калия, фосфора, мочевой кислоты. Дополнительное изучение патогенетических механизмов осложнения, определение ключевых мишеней лекарственной терапии и мультидисциплинарный подход в лечении крайне прогностически неблагоприятной группы онкогематологических больных с распространенными стадиями опухолевого процесса — возможные составляющие дальнейшего повышения эффективности терапии СОЛО.
- Open Access
- 19 January 2023
- Published by ECO-Vector LLC in Russian Journal of Pediatric Surgery, Anesthesia and Intensive Care
- Vol. 12 (4) , 453-460
Methods of local anesthesia in postoperative anesthesia of oncosurgical operations on the nasopharynx in children
BACKGROUND: Postoperative analgesia should begin even in the operating room, so that at the time of awakening the patient does not experience pain and discomfort. The work is devoted to the problems of postoperative analgesia using local anesthesia techniques in oncosurgery of the nasopharynx in children. AIM: The aim of the study to analyze the primary results of the use of local anesthesia methods in postoperative analgesia in pediatric oncosurgery of the nasopharynx. MATERIALS AND METHODS: A study was conducted in the immediate postoperative period (16 hours) in ten patients, whose average age was 14 years with ENT surgical pathology. The physical status of the children corresponded to the III class according to the ASA classification. The patients were divided into two equal groups of 5 people: the 1st group included children who, for the purpose of postoperative analgesia at the end of the surgical intervention, underwent conduction anesthesia of the nose from three points according to Weisblat; the 2nd group (comparison group) is represented by patients in whom infraorbital anesthesia was used after surgery. Non-invasive monitoring of systolic and diastolic blood pressure, heart rate was carried out. The oxygen status was monitored by pulse oximetry. RESULTS: The data obtained from the analysis of hemodynamic parameters, pain assessment by VAS (Visual Analog Scale) testified to the effectiveness of pain relief in patients in the study groups. The main hemodynamic parameters and pain assessment data for the groups were similar to each other and were within the reference values. There were differences in the duration of postoperative analgesia. CONCLUSIONS: The proposed methods of postoperative analgesia make it possible to abandon the use of narcotic drugs, synthetic opioid analgesics, non-steroidal anti-inflammatory drugs, but not excluding analgesics antipyretics. The positive first results of this study provide for the need for a further set of observations, possibly in different clinics due to the relative rarity of oncological pathology of the nasopharynx in childhood.
- 19 January 2023
- Published by ECO-Vector LLC in Russian Journal of Pediatric Surgery, Anesthesia and Intensive Care
- Vol. 12 (4) , 453-460
Open AccessMethods of local anesthesia in postoperative anesthesia of oncosurgical operations on the nasopharynx in children
BACKGROUND: Postoperative analgesia should begin even in the operating room, so that at the time of awakening the patient does not experience pain and discomfort. The work is devoted to the problems of postoperative analgesia using local anesthesia techniques in oncosurgery of the nasopharynx in children. AIM: The aim of the study to analyze the primary results of the use of local anesthesia methods in postoperative analgesia in pediatric oncosurgery of the nasopharynx. MATERIALS AND METHODS: A study was conducted in the immediate postoperative period (16 hours) in ten patients, whose average age was 14 years with ENT surgical pathology. The physical status of the children corresponded to the III class according to the ASA classification. The patients were divided into two equal groups of 5 people: the 1st group included children who, for the purpose of postoperative analgesia at the end of the surgical intervention, underwent conduction anesthesia of the nose from three points according to Weisblat; the 2nd group (comparison group) is represented by patients in whom infraorbital anesthesia was used after surgery. Non-invasive monitoring of systolic and diastolic blood pressure, heart rate was carried out. The oxygen status was monitored by pulse oximetry. RESULTS: The data obtained from the analysis of hemodynamic parameters, pain assessment by VAS (Visual Analog Scale) testified to the effectiveness of pain relief in patients in the study groups. The main hemodynamic parameters and pain assessment data for the groups were similar to each other and were within the reference values. There were differences in the duration of postoperative analgesia. CONCLUSIONS: The proposed methods of postoperative analgesia make it possible to abandon the use of narcotic drugs, synthetic opioid analgesics, non-steroidal anti-inflammatory drugs, but not excluding analgesics antipyretics. The positive first results of this study provide for the need for a further set of observations, possibly in different clinics due to the relative rarity of oncological pathology of the nasopharynx in childhood.
- Open Access
- 19 December 2022
- Published by ECO-Vector LLC in Regional Anesthesia and Acute Pain Management
- Vol. 16 (4) , 255-266
Perioperative anesthesia in children with oncological diseases: prospective single-center continuous cohort study of a 6-year clinical experience
BACKGROUND: Effective anesthesia is one of the most important factors in rapid and successful rehabilitation after surgery. Inadequately selected analgesia and consequent pain significantly slow down the recovery process and are associated with several complications that cover almost all organs and systems and reduce the patients quality of life in the long term. OBJECTIVE: This study aimed to analyze 6 years of clinical experience with perioperative epidural anesthesia in the Research Institute of Pediatric Oncology, considering the effectiveness, safety, and satisfaction of patients and their legal representatives with this medical aid. MATERIALS AND METHODS: A prospective single-center continuous cohort study was conducted on patients who received epidural analgesia as part of perioperative anesthesia in the period from 2016 to 2021. Data from 702 (48.5%) boys and 745 (51.5%) girls were analyzed. Children were divided into three main groups according to age: from 1 month to 1 year (14.3%), from 1 year to 7 years (37.8%), and from 8 years to 18 years (47.8%). The area of surgical intervention was also considered: abdominal surgery (65.2%), thoracic (8.5%), and orthopedic (26.4%). The choice of the local anesthesia level has also influenced the results. The main study outcomes were the intensity of postoperative pain syndrome in pediatric oncosurgery and additional consumption of narcotic analgesics after the administration of a mixture of topical drugs with or without adjuvants into the epidural space. RESULTS: The effectiveness of epidural anesthesia in the intraoperative period was quite high, which is confirmed by the stability of hemodynamic parameters. Intraoperatively, additional administration of systemic narcotic analgesics was noted in 5% of the total sample. In all observed patients, epidural adjuvants (morphine and promedol) ensured the optimal duration of action and analgesic efficacy of caudal blockade in the postoperative period; therefore, additional painkillers were not needed. Satisfaction with the intervention was generally high, with 98% providing a rating of very good or good. CONCLUSION: Anesthesia methods (epidural blockade), optimal pain control, and active postoperative recovery (including early oral nutrition and mobilization) in fast-track surgery reduce stress reactions and organ dysfunction, significantly reducing the time required for a full recovery.
- 19 December 2022
- Published by ECO-Vector LLC in Regional Anesthesia and Acute Pain Management
- Vol. 16 (4) , 255-266
Open AccessPerioperative anesthesia in children with oncological diseases: prospective single-center continuous cohort study of a 6-year clinical experience
BACKGROUND: Effective anesthesia is one of the most important factors in rapid and successful rehabilitation after surgery. Inadequately selected analgesia and consequent pain significantly slow down the recovery process and are associated with several complications that cover almost all organs and systems and reduce the patients quality of life in the long term. OBJECTIVE: This study aimed to analyze 6 years of clinical experience with perioperative epidural anesthesia in the Research Institute of Pediatric Oncology, considering the effectiveness, safety, and satisfaction of patients and their legal representatives with this medical aid. MATERIALS AND METHODS: A prospective single-center continuous cohort study was conducted on patients who received epidural analgesia as part of perioperative anesthesia in the period from 2016 to 2021. Data from 702 (48.5%) boys and 745 (51.5%) girls were analyzed. Children were divided into three main groups according to age: from 1 month to 1 year (14.3%), from 1 year to 7 years (37.8%), and from 8 years to 18 years (47.8%). The area of surgical intervention was also considered: abdominal surgery (65.2%), thoracic (8.5%), and orthopedic (26.4%). The choice of the local anesthesia level has also influenced the results. The main study outcomes were the intensity of postoperative pain syndrome in pediatric oncosurgery and additional consumption of narcotic analgesics after the administration of a mixture of topical drugs with or without adjuvants into the epidural space. RESULTS: The effectiveness of epidural anesthesia in the intraoperative period was quite high, which is confirmed by the stability of hemodynamic parameters. Intraoperatively, additional administration of systemic narcotic analgesics was noted in 5% of the total sample. In all observed patients, epidural adjuvants (morphine and promedol) ensured the optimal duration of action and analgesic efficacy of caudal blockade in the postoperative period; therefore, additional painkillers were not needed. Satisfaction with the intervention was generally high, with 98% providing a rating of very good or good. CONCLUSION: Anesthesia methods (epidural blockade), optimal pain control, and active postoperative recovery (including early oral nutrition and mobilization) in fast-track surgery reduce stress reactions and organ dysfunction, significantly reducing the time required for a full recovery.
- Open Access
- 7 November 2022
- Published by Publishing House ABV Press in Oncohematology
- Vol. 17 (4) , 185-195
Tumour lysis syndrome: modern aspects of the problem
Background. Acute tumor lysis syndrome (ATLS) complicates the treatment of highly aggressive leukemias and lymphomas in children and leads to death in 21.4 % of severe cases. ATLS is based on the death of tumor cells, so the volume of decay products exceeds the excretory capacity of the kidneys. The ATLS risk group includes patients with acute lymphoblastic leukemia accompanied by hyperleukocytosis (above 100 × 109/L) and non-Hodgkin’s lymphomas with a large tumor mass (stage III–Iv of the disease). The development of acute renal and then multiple organ failure require intensive monitoring of ATLS clinical and biochemical markers and the development of optimal patient management tactics jointly by an intensive care physician and a pediatric oncologist-hematologist.Aim. To summarize the literature and our own clinical experience in the diagnosis and treatment of ATLS in pediatric oncohematology.Materials and methods. The literature data on the diagnosis and treatment of ATLS in children with oncohematological diseases were analyzed. Summarized own clinical experience from January 2009 to January 2022.Results. Of 379 patients with acute lymphoblastic leukemia and non-Hodgkin’s lymphomas, who are at risk for developing ATLS, 350 (93.4 %) patients underwent conservative ATLS therapy, of which in 31 (8.8 %) cases, hemodiafiltration was required to eliminate tumor decay products. The average number of hemodiafiltration procedures is 3 (from 1 to 15). Nevertheless, despite the whole range of therapeutic measures, the addition of infectious and multiple organ complications caused death in 7 (22.6 %) of 31 patients. Most (5 out of 7) fatal cases occurred between 2009 and 2013, and the number of lethal cases because of ATLS from 2014 to 2022 years were only 2. In 24 (77.4 %) patients, the signs of ATLS were successfully managed, the patients continued antitumor treatment. when observing patients for 6 years (from 7 months to 13 years), there were no signs of disease relapse, as well as renal dysfunction.Conclusion. prevention and treatment of ATLS, including cytoreductive prephase, infusion therapy, allopurinol and rasburicase, and in case of ineffectiveness, hemodiafiltration is the basis of modern intensive therapy for hematological malignancies in children. Additional study of the pathogenetic mechanisms of ATLS development, identification of key targets of drug therapy, and a multidisciplinary approach in the treatment of an extremely unfavorable group of oncohematological patients with advanced stages of the tumor process are possible components for further increasing the effectiveness of ATLS therapy.
- 7 November 2022
- Published by Publishing House ABV Press in Oncohematology
- Vol. 17 (4) , 185-195
Open AccessTumour lysis syndrome: modern aspects of the problem
Background. Acute tumor lysis syndrome (ATLS) complicates the treatment of highly aggressive leukemias and lymphomas in children and leads to death in 21.4 % of severe cases. ATLS is based on the death of tumor cells, so the volume of decay products exceeds the excretory capacity of the kidneys. The ATLS risk group includes patients with acute lymphoblastic leukemia accompanied by hyperleukocytosis (above 100 × 109/L) and non-Hodgkin’s lymphomas with a large tumor mass (stage III–Iv of the disease). The development of acute renal and then multiple organ failure require intensive monitoring of ATLS clinical and biochemical markers and the development of optimal patient management tactics jointly by an intensive care physician and a pediatric oncologist-hematologist.Aim. To summarize the literature and our own clinical experience in the diagnosis and treatment of ATLS in pediatric oncohematology.Materials and methods. The literature data on the diagnosis and treatment of ATLS in children with oncohematological diseases were analyzed. Summarized own clinical experience from January 2009 to January 2022.Results. Of 379 patients with acute lymphoblastic leukemia and non-Hodgkin’s lymphomas, who are at risk for developing ATLS, 350 (93.4 %) patients underwent conservative ATLS therapy, of which in 31 (8.8 %) cases, hemodiafiltration was required to eliminate tumor decay products. The average number of hemodiafiltration procedures is 3 (from 1 to 15). Nevertheless, despite the whole range of therapeutic measures, the addition of infectious and multiple organ complications caused death in 7 (22.6 %) of 31 patients. Most (5 out of 7) fatal cases occurred between 2009 and 2013, and the number of lethal cases because of ATLS from 2014 to 2022 years were only 2. In 24 (77.4 %) patients, the signs of ATLS were successfully managed, the patients continued antitumor treatment. when observing patients for 6 years (from 7 months to 13 years), there were no signs of disease relapse, as well as renal dysfunction.Conclusion. prevention and treatment of ATLS, including cytoreductive prephase, infusion therapy, allopurinol and rasburicase, and in case of ineffectiveness, hemodiafiltration is the basis of modern intensive therapy for hematological malignancies in children. Additional study of the pathogenetic mechanisms of ATLS development, identification of key targets of drug therapy, and a multidisciplinary approach in the treatment of an extremely unfavorable group of oncohematological patients with advanced stages of the tumor process are possible components for further increasing the effectiveness of ATLS therapy.